FDA panel on Pfizer, Moderna shots for young kids

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.The Food and Drug Administration's vaccine advisers gave a thumbs-up to vaccines from Moderna and Pfizer for the littlest kids.

The outside experts voted unanimously that the benefits of the shots outweigh any risks for children under 5. That's roughly 18 million youngsters.They are the last age group in the U.S. without access to COVID-19 vaccines and many parents have been anxious to protect their little children.FDA reviewers said both brands appear to be safe and effective for children as young as 6 months old in analyses posted ahead of the all-day meeting. If the FDA agrees with its advisers and authorizes the shots, there's one more step.The Centers for Disease Control and Prevention will decide on a formal recommendation after its own advisers meet Saturday.If the CDC signs off, shots could be available as soon as Monday or Tuesday at doctor's offices, hospitals and pharmacies.